Apurba wins a project to build a next-generation natural language platform that leverages AI to optimize the operation and management of clinical trials
Added on 15th January 2018
SUNNYVALE, Calif., Jan 15th, 2018 – Apurba wins a project to build a next-generation natural language platform that leverages AI to optimize the operation and management of clinical trials.
Companies that fund clinical trials currently lose billions of dollars per year due to of failures related to protocol deviations, recruitment issues, and corrupted or improperly recorded data. The two root causes of these failures are related to study design and execution, both of which conspire to produce a status quo wherein 50% of effective treatments fail to acquire FDA approval, keeping lifesaving medical breakthroughs away from the patients whose lives depend on them. This platform will apply artificial intelligence to make the process of conducting clinical trials safer, faster, and easier.
Apurba Technologies Inc. is a Sunnyvale, CA, based software development company that creates enterprise big data solutions for natural language processing, visualization and analytics.
